Brodmann area 25
| Brain: Brodmann area 25 | ||
|---|---|---|
| Brodmann area 25 is shown in orange. | ||
| Medial surface of the brain with Brodmann's areas numbered. | ||
| Latin | Area subgenualis | |
| NeuroLex ID | birnlex_1726 | |
Brodmann area 25 (BA25) is an area in the cerebral cortex of the brain and delineated based on its cytoarchitectonic characteristics. It is also called the subgenual area, area subgenualis or subgenual cingulate. It is the 25th "Brodmann area" defined by Korbinian Brodmann (thus its name). BA25 is located in the cingulate region as a narrow band in the caudal portion of the subcallosal area adjacent to the paraterminal gyrus. The posterior parolfactory sulcus separates the paraterminal gyrus from BA25. Rostrally it is bound by the prefrontal area 11 of Brodmann.[1]
Contents |
[edit] History
Brodmann described this area as it is labeled now in 1909. Originally in 1905, Brodmann labeled the area as part of area 24. In 1909, he divided the area into area 24 and 25.[2]
[edit] Function
This region is extremely rich in serotonin transporters and is considered as a governor for a vast network involving areas like hypothalamus and brain stem, which influences changes in appetite and sleep; the amygdala and insula, which affect the mood and anxiety; the hippocampus, which plays an important role in memory formation; and some parts of the frontal cortex responsible for self-esteem.[3]
[edit] Involvement in depression
The subcallosal cingulate gyrus which consists of BA25 as well as parts of BA24 and BA32 has been implicated as playing an important role in major depression and has been the target of deep brain stimulation to treat that disease.[4]
One study found that BA25 is metabolically overactive in treatment-resistant depression.[5] A different study found that metabolic hyperactivity in this area is associated with poor therapeutic response of persons with Major Depressive Disorder to cognitive-behavioral therapy and venlafaxine.[6]
In 2011 Helen S. Mayberg and collaborators described how they successfully treated a number of depressed people — individuals virtually catatonic with depression despite years of talk therapy, drugs, even shock therapy — with pacemaker-like electrodes (deep brain stimulation) in area 25. [7]
A decade earlier, Mayberg had identified area 25 as a key conduit of neural traffic between the "thinking" frontal cortex and the phylogenetically older central limbic region that gives rise to emotion. She subsequently found that area 25 appeared overactive in these depressed people — "like a gate left open," as she puts it — allowing negative emotions to overwhelm thinking and mood. Inserting the electrodes closed this gate and rapidly alleviated the depression of two-thirds of the trial's patients.[8]
[edit] Image
-
Animation.
-
Medial view.
[edit] Notes and references
- ^ subgenual area 25. braininfo.rprc.washington.edu, retrieved November 18, 2006.
- ^ area 25 of Brodmann-1909. braininfo.rprc.washington.edu, retrieved November 19, 2006.
- ^ "Faulty Circuits", Scientific American, April 2010
- ^ Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM. (15 February 2011). "The subcallosal cingulate gyrus in the context of major depression". Biological Psychiatry 69 (4): 301–309. PMID 21145043.
- ^ Deep Brain Stimulation for Treatment-Resistant Depression neuron.org, March 3, 2005. Retrieved November 18, 2006.
- ^ Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder cma.ca, May 2009. Retrieved May 23, 2009.
- ^ Lozano, Andres M; Peter Giacobbe, Clement Hamani, Sakina J Rizvi, Sidney H Kennedy, Theodore T Kolivakis, Guy Debonnel, Abbas F Sadikot, Raymond W Lam, Andrew K Howard, Magda Ilcewicz-Klimek, Christopher R Honey, Helen S Mayberg (2011-11-18). "A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression". Journal of Neurosurgery. doi:10.3171/2011.10.JNS102122. PMID 22098195.
- ^ Mayberg HS, Lozano AM, Voon V, et al. (March 2005). "Deep brain stimulation for treatment-resistant depression". Neuron 45 (5): 651–60. doi:10.1016/j.neuron.2005.02.014. PMID 15748841. http://www.cell.com/neuron/fulltext/S0896-6273(05)00156-X.
[edit] See also
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||